Oncology & Cancer

TTFields tied to improved survival in glioblastoma patients

(HealthDay)—For patients with glioblastoma, the addition of tumor-treating fields (TTFields) to standard treatment with temozolomide is associated with improved survival without negative effects on health-related quality ...

Oncology & Cancer

Probability of long-term glioblastoma survival assessed

(HealthDay) -- Although the overall mortality rate of glioblastoma is high, compared with patients newly diagnosed with glioblastoma, those who survive two years or more after diagnosis have a favorable conditional probability ...

Oncology & Cancer

The hitchhiker's guide to defeating glioblastoma

In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside cells—have been a source of both excitement and disappointment. While preclinical studies have found that microRNAs play ...

Oncology & Cancer

New insights for a therapeutic approach in glioblastoma

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically increased ...

Oncology & Cancer

Custom-tailored strategy against glioblastomas

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers at the University ...

page 7 from 23